NCT00701727View on ClinicalTrials.gov

Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Hypercholesterolemia
Interventions
DRUG

ezetimibe

1 tablet,10mg, once a day, for 7 weeks

DRUG

Placebo

1 tablet, once a day, for 7 weeks

Trial Locations (1)

60610

Radiant Research, Chicago

Sponsors

Lead Sponsor

Radiant Research
All Listed Sponsors
lead

Radiant Research

OTHER

NCT00701727 - Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study | Biotech Hunter | Biotech Hunter